Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease

被引：107
作者：
Belvisi, Maria G. [1 ]
Mitchell, Jane A. [2 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Resp Pharmacol Grp, London SW7 2AZ, England
[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Cardiovasc Pharmacol Grp, London SW7 2AZ, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2009年 / 158卷 / 04期
基金：
英国生物技术与生命科学研究理事会;
关键词：
peroxisome proliferator-activated receptor; asthma; COPD; inflammation; fibrosis; 15-deoxy-Delta(12,14)-PGJ(2) (15-PGJ(2)); PROLIFERATOR-ACTIVATED RECEPTORS; NF-KAPPA-B; GAMMA AGONISTS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); MURINE MODEL; ANTIINFLAMMATORY ACTIONS; THERAPEUTIC TARGET; NITRIC-OXIDE; ALPHA; EXPRESSION;
D O I：
10.1111/j.1476-5381.2009.00373.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
This article is part of a themed issue on Mediators and Receptors in the Resolution of Inflammation. To view this issue visit http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2009.
引用
收藏
页码：994 / 1003
页数：10
相关论文
共 85 条
[1]   Human bone marrow megakaryocytes and platelets express PPARγ, and PPARγ agonists blunt platelet release of CD40 ligand and thromboxanes [J].
Akbiyik, F ;
Ray, DM ;
Gettings, KF ;
Blumberg, N ;
Francis, CW ;
Phipps, RP .
BLOOD, 2004, 104 (05) :1361-1368
[2]   Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARβ [J].
Ali, Ferhana Y. ;
Davidson, Simon J. ;
Moraes, Leonardo A. ;
Traves, Suzanne L. ;
Paul-Clark, Mark ;
Bishop-Bailey, David ;
Warner, Timothy D. ;
Mitchell, Jane A. .
FASEB JOURNAL, 2006, 20 (02) :326-328
[3]   Role of prostacyclin versus peroxisome proliferator-activated receptor β receptors in prostacyclin sensing by lung fibroblasts [J].
Ali, FY ;
Egan, K ;
FitzGerald, GA ;
Desvergne, B ;
Wahli, W ;
Bishop-Bailey, D ;
Warner, TD ;
Mitchell, JA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2006, 34 (02) :242-246
[4]   Peroxisome proliferator-activated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth [J].
Ameshima, S ;
Golpon, H ;
Cool, CD ;
Chan, D ;
Vandivier, RW ;
Gardai, SJ ;
Wick, M ;
Nemenoff, RA ;
Geraci, MW ;
Voelkel, NF .
CIRCULATION RESEARCH, 2003, 92 (10) :1162-1169
[5]   Peroxisome proliferator-activated receptor γ inhibits the migration of dendritic cells:: Consequences for the immune response [J].
Angeli, W ;
Hammad, H ;
Staels, B ;
Capron, M ;
Lambrecht, BN ;
Trottein, F .
JOURNAL OF IMMUNOLOGY, 2003, 170 (10) :5295-5301
[6]   Antiinflammatory roles of peroxisome proliferator-activated receptor γ in human alveolar macrophages [J].
Asada, K ;
Sasaki, S ;
Suda, T ;
Chida, K ;
Nakamura, H .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (02) :195-200
[7]   15-Deoxy-Δ12,14-prostaglandin J2 inhibits IL-10 and IL-12 production by macrophages [J].
Azuma, Y ;
Shinohara, R ;
Wang, PL ;
Ohura, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) :344-346
[8]   Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? [J].
Becker, Julien ;
Delayre-Orthez, Carine ;
Frossard, Nelly ;
Pons, Francoise .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2006, 20 (05) :429-447
[9]   Peroxisome proliferator-activated receptors as novel targets in lung disease [J].
Belvisi, Maria G. ;
Hele, David J. .
CHEST, 2008, 134 (01) :152-157
[10]   Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation [J].
Belvisi, MG ;
Hele, DJ ;
Birrell, MA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 533 (1-3) :101-109
123456789